{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:31:03Z","timestamp":1790242263171,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3202,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1038\/sj.mt.6300348","type":"journal-article","created":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T09:33:43Z","timestamp":1194946423000},"page":"52-59","source":"Crossref","is-referenced-by-count":57,"title":["Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo"],"prefix":"10.1016","volume":"16","author":[{"given":"Marianne M","family":"Stanford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mae","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Werden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe-Alexandre","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Bondy-Denomy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann F","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"McFadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.mt.6300348_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000441-190412740-00001","article-title":"Influence of complicating diseases upon leukemia","volume":"127","author":"Dock","year":"1904","journal-title":"Am J Med Sci"},{"key":"10.1038\/sj.mt.6300348_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1566523024605582","article-title":"Oncolytic viruses: programmable tumour hunters","volume":"2","author":"Bell","year":"2002","journal-title":"Curr Gene Ther"},{"key":"10.1038\/sj.mt.6300348_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1634\/theoncologist.7-2-106","article-title":"Viral oncolysis","volume":"7","author":"Mullen","year":"2002","journal-title":"Oncologist"},{"key":"10.1038\/sj.mt.6300348_bib4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/sj.mt.6300348_bib5","first-page":"435","article-title":"Selectively replicating oncolytic adenoviruses as cancer therapeutics","volume":"4","author":"Yu","year":"2002","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/sj.mt.6300348_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4161\/cbt.4.5.1820","article-title":"Viral oncolysis by herpes simplex virus and other viruses","volume":"4","author":"Kuruppu","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1038\/sj.mt.6300348_bib7","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1038\/sj.onc.1209041","article-title":"Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer","volume":"24","author":"Shmulevitz","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/sj.mt.6300348_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/rmv.455","article-title":"Measles as a potential oncolytic virus","volume":"15","author":"Fielding","year":"2005","journal-title":"Rev Med Virol"},{"key":"10.1038\/sj.mt.6300348_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/14712598.4.6.901","article-title":"Vaccinia as a vector for gene delivery","volume":"4","author":"Guo","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1038\/sj.mt.6300348_bib10","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1038\/sj.onc.1209037","article-title":"Oncolytic viral therapies\u2014the clinical experience","volume":"24","author":"Aghi","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/sj.mt.6300348_bib11","first-page":"108","article-title":"Myxoma virus tropism in human tumor cells","volume":"8","author":"Sypula","year":"2004","journal-title":"Gene Ther Mol Biol"},{"key":"10.1038\/sj.mt.6300348_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1574-6976.2000.tb00536.x","article-title":"Adventures with poxviruses of vertebrates","volume":"24","author":"Fenner","year":"2000","journal-title":"FEMS Microbiol Rev"},{"key":"10.1038\/sj.mt.6300348_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1051\/vetres:2006054","article-title":"Myxoma virus in the European rabbit: interactions between the virus and its susceptible host","volume":"38","author":"Stanford","year":"2007","journal-title":"Vet Res"},{"key":"10.1038\/sj.mt.6300348_bib14","first-page":"18","article-title":"Propagation of myxoma virus in one-day-old mice","volume":"36","author":"Andrewes","year":"1955","journal-title":"Br J Exp Pathol"},{"key":"10.1038\/sj.mt.6300348_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/211313a0","article-title":"Absence of serological evidence of myxoma virus infection in humans exposed during an outbreak of myxomatosis","volume":"211","author":"Jackson","year":"1966","journal-title":"Nature"},{"key":"10.1038\/sj.mt.6300348_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrmicro1099","article-title":"Poxvirus tropism","volume":"3","author":"McFadden","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1038\/sj.mt.6300348_bib17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1132","article-title":"Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier","volume":"5","author":"Wang","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1038\/sj.mt.6300348_bib18","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1073\/pnas.0509341103","article-title":"Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor","volume":"103","author":"Wang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300348_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1038\/sj.mt.6300348_bib20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/JVI.01408-06","article-title":"Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells","volume":"81","author":"Stanford","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300348_bib21","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1158\/0008-5472.CAN-05-1201","article-title":"Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas","volume":"65","author":"Lun","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300348_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/13550280701591526","article-title":"Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells","author":"Barrett","year":"2007","journal-title":"J Neurovirol"},{"key":"10.1038\/sj.mt.6300348_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/JVI.01633-06","article-title":"M135R is a novel cell surface virulence factor of myxoma virus","volume":"81","author":"Barrett","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300348_bib24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/viro.1999.0001","article-title":"The complete DNA sequence of myxoma virus","volume":"264","author":"Cameron","year":"1999","journal-title":"Virology"},{"key":"10.1038\/sj.mt.6300348_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1006\/viro.1997.8894","article-title":"The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes","volume":"239","author":"Barry","year":"1997","journal-title":"Virology"},{"key":"10.1038\/sj.mt.6300348_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/156801105774574649","article-title":"Inhibition of PI3K\/Akt signaling: an emerging paradigm for targeted cancer therapy","volume":"5","author":"Chen","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1038\/sj.mt.6300348_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.pcan.4500776","article-title":"The emerging role of the PI3-K-Akt pathway in prostate cancer progression","volume":"8","author":"Li","year":"2005","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1038\/sj.mt.6300348_bib28","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1158\/0008-5472.CAN-05-2242","article-title":"Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector","volume":"66","author":"McKee","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300348_bib29","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1158\/0008-5472.CAN-06-4260","article-title":"Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice","volume":"67","author":"Ganesh","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300348_bib30","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djj397","article-title":"Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy","volume":"98","author":"Kim","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.mt.6300348_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4741.2006.00355.x","article-title":"MBI: M(I)BI agonistes or a new chapter?","volume":"13","author":"Brenner","year":"2007","journal-title":"Breast J"},{"key":"10.1038\/sj.mt.6300348_bib32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/sj.mt.6300348_bib33","doi-asserted-by":"crossref","first-page":"8818","DOI":"10.1158\/0008-5472.CAN-07-1214","article-title":"Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin","volume":"67","author":"Lun","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300348_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/14737140.6.1.131","article-title":"From Rapa Nui to rapamycin: targeting PI3K\/Akt\/mTOR for cancer therapy","volume":"6","author":"Georgakis","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1038\/sj.mt.6300348_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1432-2277.2004.00026.x","article-title":"Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer","volume":"18","author":"Guba","year":"2005","journal-title":"Transpl Int"},{"key":"10.1038\/sj.mt.6300348_bib36","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1158\/0008-5472.CAN-05-1083","article-title":"Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells","volume":"65","author":"Paglin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300348_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.radonc.2006.11.004","article-title":"Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis","volume":"82","author":"Weppler","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1038\/sj.mt.6300348_bib38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ygyno.2005.12.019","article-title":"Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells","volume":"102","author":"Treeck","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1038\/sj.mt.6300348_bib39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1677\/erc.1.01170","article-title":"Combination therapy for treating breast cancer using antiestrogen, ERA-923, and the mammalian target of rapamycin inhibitor, temsirolimus","volume":"13","author":"Sadler","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/sj.mt.6300348_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1479-5876-3-39","article-title":"Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin","volume":"3","author":"Molhoek","year":"2005","journal-title":"J Transl Med"},{"key":"10.1038\/sj.mt.6300348_bib41","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1158\/1535-7163.MCT-06-0166","article-title":"Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors","volume":"5","author":"Buck","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/sj.mt.6300348_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1212\/01.wnl.0000223844.77636.29","article-title":"Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas","volume":"67","author":"Doherty","year":"2006","journal-title":"Neurology"},{"key":"10.1038\/sj.mt.6300348_bib43","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1089\/hum.2005.16.1473","article-title":"Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954","volume":"16","author":"Lukashev","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300348_bib44","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-05-0309","article-title":"RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer","volume":"65","author":"Homicsko","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300348_bib45","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/jnci\/57.5.1199","article-title":"Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines","volume":"57","author":"Fidler","year":"1976","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/sj.mt.6300348_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00880071","article-title":"Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines","volume":"11","author":"Morris","year":"1993","journal-title":"Clin Exp Metastasis"},{"key":"10.1038\/sj.mt.6300348_bib47","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.66.8.4720-4731.1992","article-title":"Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor","volume":"66","author":"Opgenorth","year":"1992","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300348_bib48","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1128\/JVI.77.10.5877-5888.2003","article-title":"Role of the serine-threonine kinase PAK-1 in myxoma virus replication","volume":"77","author":"Johnston","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300348_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0344-0338(11)80206-2","article-title":"Lendrum (-MSB) staining for fibrin identification in sealed skin grafts","volume":"190","author":"Fisseler-Eckhoff","year":"1994","journal-title":"Pathol Res Pract"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616313624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616313624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T01:37:11Z","timestamp":1588037831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616313624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1525001616313624"],"URL":"https:\/\/doi.org\/10.1038\/sj.mt.6300348","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}